The risk of developing diabetes during antipsychotic drug treatment: A nationwide study among 31,856 patients with schizophrenia

INTRODUCTION: Antipsychotics (AP) are the primary pharmacological treatment for schizophrenia but increase the risk for diabetes, with recent meta-analyses indicating important differences between specific APs. However, these findings are based on randomized clinical trials, which only include 20% o...

Descripción completa

Detalles Bibliográficos
Autores principales: Marker Madsen, N., Köhler-Forsberg, O., Garne Rohde, C., Aalkjær Danielsen, A., Mors, O.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10596190/
http://dx.doi.org/10.1192/j.eurpsy.2023.339

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10596190/
http://dx.doi.org/10.1192/j.eurpsy.2023.339

Ejemplares similares